Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genoil (GNOLF) Cash & Equivalents (2018 - 2025)

Genoil has reported Cash & Equivalents over the past 8 years, most recently at $10881.0 for Q3 2025.

  • Quarterly Cash & Equivalents fell 26.94% to $10881.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10881.0 through Sep 2025, down 26.94% year-over-year, with the annual reading at $12036.0 for FY2024, 15.02% up from the prior year.
  • Cash & Equivalents was $10881.0 for Q3 2025 at Genoil, down from $41938.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $41938.0 in Q2 2025 and troughed at $12.0 in Q4 2021.
  • The 5-year median for Cash & Equivalents is $10464.0 (2023), against an average of $10937.3.
  • Year-over-year, Cash & Equivalents plummeted 99.76% in 2022 and then soared 48483.33% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $12.0 in 2021, then surged by 41933.33% to $5044.0 in 2022, then surged by 107.45% to $10464.0 in 2023, then rose by 15.02% to $12036.0 in 2024, then decreased by 9.6% to $10881.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's Cash & Equivalents are $10881.0 (Q3 2025), $41938.0 (Q2 2025), and $12036.0 (Q1 2025).